Movers Roundup: Rite Aid, Nektar Therapeutics

Among the stock activity stories for Tuesday, Sept. 22, from AP Financial News:

NEW YORK (AP) — Shares of Rite Aid Corp. slipped Tuesday after a Raymond James analyst downgraded the drugstore chain, saying he expects a disappointing fiscal second quarter for the company.

NEW YORK (AP) — Nektar Therapeutics on Tuesday said its drug candidate NKTR-102 was effective in early studies as a treatment for ovarian cancer, and said it started a midstage clinical trial.

PHILADELPHIA (AP) — Shares of Brandywine Realty Trust advanced Tuesday after the company improved its cash position by raising $250 million in unsecured debt due in five years.

NEW YORK (AP) — Shares of Lincare Holdings Inc., which provides home delivery of oxygen and other respiratory therapies, rose to an annual high Tuesday after a Citi Investment Research analyst placed the stock on a recommended list.

HARTFORD, Conn. (AP) — Shares of Boise Inc., a paper packaging manufacturer, jumped Tuesday as an analyst doubled his price target, suggesting its shares could see upside of nearly 60 percent over the next year.

NEW YORK (AP) — An attractive stock price and strong financial position led an analyst to boost Pinnacle Entertainment Inc.'s rating on Tuesday.